Filing Details
- Accession Number:
- 0001209191-20-007756
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-02-10 07:54:06
- Reporting Period:
- 2019-12-23
- Accepted Time:
- 2020-02-10 07:54:06
- Original Submission Date:
- 2019-12-26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Adverum Biotechnologies Inc. | ADVM | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1233539 | D Leone Patterson | C/O Adverum Biotechnologies, Inc. 1035 O'Brien Drive Menlo Park CA 94025 | Ceo, President And Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-23 | 40,000 | $10.72 | 150,220 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was pursuant to a 10b5-1 Plan.
- Represents weighted average sales price. The shares were sold at prices ranging from $10.30 to $11.055. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This Form 4 amendment is being filed solely to correct the number of shares held by the undersigned following this transaction.
Billionaire Hedge Funds
